SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Paschos, G. K.
Right arrow Articles by Zampelas, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paschos, G. K.
Right arrow Articles by Zampelas, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Dietary Fats
*Dietary Supplements
*Genetics Home Reference
Hazardous Substances DB
*LINSEED OIL
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Apolipoprotein E Genotype in Dyslipidemic Patients and Response of Blood Lipids and Inflammatory Markers to Alpha-Linolenic Acid

George K. Paschos, BSc

Department of Nutrition and Dietetics, Harokopio University, Athens

Nikos Yiannakouris, PhD

Department of Home Economics and Ecology, Harokopio University, Athens

Loukianos S. Rallidis, MD

Department of Cardiology, General Hospital of Nikea, Piraeus, Greece

Ian Davies, PhD

Centre for Nutrition and Food Safety, School of Biomedical and Life Sciences, University of Surrey, Guildford, UK

Bruce A. Griffin, PhD

Centre for Nutrition and Food Safety, School of Biomedical and Life Sciences, University of Surrey, Guildford, UK

Demosthenes B. Panagiotakos, PhD

Department of Nutrition and Dietetics, Harokopio University, Athens

Fotini N. Skopouli

Department of Nutrition and Dietetics, Harokopio University, Athens

Vasilios Votteas, MD

Department of Cardiology, Laiko Hospital, University of Athens, Athens, Greece

Antonis Zampelas, PhD

Department of Nutrition and Dietetics, Harokopio University, Athens, azampelas{at}hua.gr

The objective of this study was to determine the effect of alpha-linolenic acid (ALA) supplementation on blood lipids and inflammatory markers, in relation to apolipoprotein (apo) E genotype. The diets of 50 dyslipidemic male patients were supplemented with 15 mL of flaxseed oil per day for 12 weeks. Retrospectively, 3 apo E genotype variants were found ({epsilon}2/{epsilon}3, n=7; {epsilon}3/{epsilon}3, n=33; {epsilon}3/{epsilon}4, n=10). No significant differences were found among apo E genotypes in any variables at baseline. ALA supplementation produced a small but significant decrease in high-density lipoprotein cholesterol (from 1.12 to 1.08 mmol/L, 43 to 42 mg/dL; p=0.008) and apo A-I levels (from 1.28 to 1.24 g/L, p=0.036) in the {epsilon}3/{epsilon}3 homozygotes. In addition, ALA supplementation resulted in a significant decrease in the serum concentration of serum amyloid A (SAA) (p=0.014), C-reactive protein (CRP) (p=0.013), macrophage colony-stimulating factor (MCSF) (p<0.001), and interleukin (IL)-6 (p=0.028). Serum SAA and MCSF were also significantly decreased in the {epsilon}3/{epsilon}4 group (p=0.005 and p=0.017, respectively). In contrast, ALA produced no effects on any of the inflammatory markers in the {epsilon}2/{epsilon}3 group. ALA may have beneficial effects on inflammation in dyslipidemic carriers of the apo {epsilon}3/{epsilon}3 and {epsilon}3/{epsilon}4 genotypes, but not in carriers of the {epsilon}2 allele.

Angiology, Vol. 56, No. 1, 49-60 (2005)
DOI: 10.1177/000331970505600107


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement